Argatroban - Cas No. 74863-84-6, C23h36n6o5s Molecular Formula, 99% Min Purity White Powder Anticoagulant For Pharmaceutical Applications

1g Bag/Bags

1 Ton/Tons

1 Gram/Grams

C23H36N6O5S

C23H38N6O6S

C23H36N6O5S

21R-Argatroban

(2r,4r)-4-methyl-1-[n-[(3-methyl-1,2,3,4-tetrahydro-8-quinolinyl)sulfonyl]-l-arginyl]-2-piperidinecarboxylic acid;(2r,4r)-1-[(2s)-5-[(aminoiminomethyl)amino]-1-oxo-2-[[(1,2,3,4-tetrahydro-3-methyl-8-quinolinyl)sulfonyl]amino]pentyl]-4-methyl-2-piperidinecarboxylic acid

Argatroban is an anticoagulant that is a small molecule direct thrombin inhibitor. In 2000, argatroban was licensed by the Food and Drug Administration (FDA) for prophylaxis or treatment of thrombosis in patients with heparin-induced thrombocytopenia (HIT). In 2002, it was approved for use during percutaneous coronary interventions in patients who have HIT or are at risk for developing it. In 2012, it was approved by the MHRA in the UK for anticoagulation in patients with heparin-induced thrombocytopenia Type II (HIT) who require parenteral antithrombotic therapy.

Argatroban is used as an anticoagulant in individuals with thrombosis and heparin induced thrombocytopenia. Often these individuals require long term anticoagulation.

white powder

white solid

Shanghai

Shanghai

1000kg Per Day

1000 Per Week

1 Per Week

Yes

Yes

foil/bag/bottle

foil/bag/bottle